Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology · CARD9 Deficiency

Long-Term Monitoring and Survivorship

At a Glance

Long-term survivorship care for CARD9 deficiency focuses on detecting recurrent invasive fungal infection early through individualized monitoring, safely continuing antifungal therapy, checking affected organs, supporting mental health, and assessing siblings genetically.

Managing a CARD9 deficiency is not just about treating a single infection; it is a long-term commitment to vigilance and health maintenance. Because the immune system’s specific vulnerability for fungi does not go away, “survivorship” in this context means working with your medical team on a customizable checklist covering prior infection sites, specialist appointments, adherence, and family genetics [1][2].

The Challenge of Relapse

The most critical thing to understand about long-term life with CARD9 deficiency is the high risk of recurrence. In one large review of patients who initially responded to treatment, 44 out of 45 patients eventually experienced a return of their fungal infection [1].

Relapses can happen weeks, months, or even years after you finish treatment [3]. For this reason, many doctors view CARD9 deficiency as a chronic condition that requires permanent or long-term suppressive therapy (preventive antifungal medication) rather than a one-time cure [4][2].

Long-Term Monitoring Strategy

Because symptoms can be subtle, regular monitoring is the best way to catch a returning infection early. There is no universal schedule; monitoring is individualized:

  • Imaging Surveillance: If you have had a brain infection (CNS candidiasis), your team might schedule follow-up MRIs to ensure no new lesions are forming. However, imaging is generally individualized to the prior lesions and clinical course rather than being a routine screening for everyone [5][6].
  • Microbiologic Checks: This may involve repeated blood tests or, if symptoms return, checking your spinal fluid (CSF) for the presence of fungal DNA or culture growth [7][6]. Lumbar puncture has procedural risks and is usually guided by symptoms or a specific treatment decision, not performed routinely.
  • Drug Level Monitoring: If you are on lifelong antifungals, you will need periodic medication-specific laboratory tests to check drug levels and ensure the medication isn’t causing side effects in your liver, kidneys, or heart [8][9].

Managing Organ Morbidity

Severe fungal infections can occasionally leave lasting “scars” on the body. Depending on where your infection was, you may need specialized follow-up care for specific, uncommon complications:

  • Neurological Care: Brain infections can lead to long-term issues like hydrocephalus (fluid buildup), which may require a shunt, or cerebral vasculitis (inflammation of the brain’s blood vessels) [10][11].
  • Vision Health: Fungal infections in the eye (endophthalmitis) can cause irreversible vision loss. Regular exams by an ophthalmologist are vital for anyone who has had facial or eye-related fungal symptoms [4][12].
  • Bone and Joint Support: Infections that move into the bone (osteomyelitis) can lead to the need for joint replacements or, in rare and severe cases, amputation to stop the spread [4][13].

The Psychological Toll

Living with a rare genetic condition and a high risk of relapse can be mentally exhausting. It is common to experience:

  • Scan Anxiety: Intense stress or fear leading up to regular MRI or CT scans.
  • Medication Fatigue: The frustration of needing to take pills every single day for years on end.
  • Social Isolation: Feeling that others don’t understand your “invisible” immune defect.

Seeking support from a mental health professional who specializes in chronic illness or joining a patient support group for inborn errors of immunity can be a vital part of your care plan [1].

Family Considerations

Because CARD9 deficiency is an autosomal recessive condition, it is a family matter. It is possible for siblings to have the same genetic mutation but have not yet developed an infection [14].

  • Cascade Screening: Genetic counseling and targeted familial-variant testing for siblings is strongly recommended [1].
  • Early Vigilance: If a sibling is found to have the biallelic variants, they can be established with a specialist. Any treatment decision still requires clinical assessment and usually organism confirmation; genotype alone is not a reason to self-start systemic antifungal medication [14].

Common questions in this guide

How likely is a fungal infection to come back with CARD9 deficiency?
The risk of recurrence is high, even after treatment seems successful. A fungal infection can return weeks, months, or years later, so ongoing follow-up and any prescribed long-term suppressive antifungal therapy are important.
What tests are used to monitor CARD9 deficiency over time?
There is no single schedule for everyone. Depending on your prior infection and symptoms, monitoring may include follow-up MRI, blood tests, or testing of spinal fluid; lumbar puncture is generally reserved for a clinical concern or a specific treatment decision rather than routine screening.
What should be checked if I take antifungal medicine long term?
Your clinicians may check medication levels and perform regular laboratory tests to watch for effects on the liver, kidneys, or heart. The exact tests and timing depend on the antifungal drug and your health history.
Which specialists may I need after an invasive fungal infection?
Follow-up depends on the organs affected. A neurologist may monitor a prior brain infection or fluid buildup in the brain, an ophthalmologist can evaluate eye involvement and vision, and other specialists may be added for bone, joint, or other lasting problems.
Should my siblings be tested for CARD9 deficiency?
Because CARD9 deficiency is inherited in an autosomal recessive pattern, a sibling can carry the same two disease-causing variants without having had an infection yet. Genetic counseling and targeted testing for the known family variant can help clarify risk, but a genetic result alone is not a reason to start antifungal medicine without medical assessment.
How can I cope with the stress of lifelong monitoring?
Scan anxiety, medication fatigue, and feeling isolated are common burdens of living with a rare immune condition. A mental health professional familiar with chronic illness or a support group for inborn errors of immunity may help you build coping and medication routines.

Get notified when new evidence is published on Predisposition to invasive fungal disease due to CARD9 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.

    Corvilain E, Casanova JL, Puel A

    Journal of clinical immunology 2018; (38(6)):656-693 doi:10.1007/s10875-018-0539-2.

    PMID: 30136218
  2. 2

    Clinical features of patients with fungal infections caused by CARD9 deficiency: a literature review of case reports.

    Tang C, Liu Y, Long J, Lv X

    Frontiers in cellular and infection microbiology 2025; (15()):1615929 doi:10.3389/fcimb.2025.1615929.

    PMID: 40740345
  3. 3

    Inherited CARD9 Deficiency in a Patient with Both Exophiala spinifera and Aspergillus nomius Severe Infections.

    Perez L, Messina F, Negroni R, et al.

    Journal of clinical immunology 2020; (40(2)):359-366 doi:10.1007/s10875-019-00740-2.

    PMID: 31940125
  4. 4

    Endogenous Candida endophthalmitis and osteomyelitis associated with CARD9 deficiency.

    Jones N, Garcez T, Newman W, Denning D

    BMJ case reports 2016; (2016()).

    PMID: 26941346
  5. 5

    A 7-Year-Old Child With Headaches and Prolonged Fever Associated With Oral and Nail Lesions.

    Martin S, Balligand E, Peeters J, et al.

    Open forum infectious diseases 2019; (6(11)):ofz229 doi:10.1093/ofid/ofz229.

    PMID: 31700940
  6. 6

    Intracranial infections of Candida albicans and Mycobacterium intracellulare associated with CARD9 deficiency: case report and review of literature.

    Tang C, Chen C, Lv X, et al.

    Frontiers in immunology 2025; (16()):1648436 doi:10.3389/fimmu.2025.1648436.

    PMID: 41041311
  7. 7

    [CARD9 Mutation in a Patient with Candida albicans Meningoencephalitis; A Case Report].

    Kuruoğlu T, Çelik M, Çelmeli F, Tanyel E

    Mikrobiyoloji bulteni 2021; (55(4)):656-664 doi:10.5578/mb.20219717.

    PMID: 34666665
  8. 8

    Invasive cerebral phaeohyphomycosis in a Chinese boy with CARD9 deficiency and showing unique radiological features, managed with surgical excision and antifungal treatment.

    Lai SHY, Duque JSR, Chung BH, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021; (107()):59-61 doi:10.1016/j.ijid.2021.04.052.

    PMID: 33872781
  9. 9

    Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.

    Stott KE, Hope WW

    The Journal of antimicrobial chemotherapy 2017; (72(suppl_1)):i12-i18 doi:10.1093/jac/dkx029.

    PMID: 28355463
  10. 10

    [A case of Candida meningitis in a patient with CARD9 deficiency: an autopsy report].

    Katakami T, Ueda T, Nagata M, et al.

    Rinsho shinkeigaku = Clinical neurology 2024; (64(9)):648-653 doi:10.5692/clinicalneurol.cn-001980.

    PMID: 39183049
  11. 11

    Pearls & Oy-sters: Spinal Cord Candidiasis Linked to CARD9 Deficiency Masquerading as a Longitudinally Extensive Transverse Myelitis.

    Jeantin L, Plu I, Amador MDM, et al.

    Neurology 2022; (99(11)):475-479 doi:10.1212/WNL.0000000000200992.

    PMID: 35794021
  12. 12

    Novel bi-allelic splice mutations in CARD9 causing adult-onset Candida endophthalmitis.

    Gavino C, Mellinghoff S, Cornely OA, et al.

    Mycoses 2018; (61(1)):61-65 doi:10.1111/myc.12701.

    PMID: 28984994
  13. 13

    Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature review.

    Ansai O, Hayashi R, Nakamura A, et al.

    The Journal of dermatology 2024; (51(2)):294-300 doi:10.1111/1346-8138.16995.

    PMID: 37804063
  14. 14

    Inherited CARD9 Deficiency in a Child with Invasive Disease Due to Exophiala dermatitidis and Two Older but Asymptomatic Siblings.

    Imanaka Y, Taniguchi M, Doi T, et al.

    Journal of clinical immunology 2021; (41(5)):975-986 doi:10.1007/s10875-021-00988-7.

    PMID: 33558980

This page provides educational information about long-term monitoring and survivorship with CARD9 deficiency and is not medical advice. Your care team should personalize antifungal treatment, follow-up testing, organ checks, and genetic counseling.